Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;28(6):645-653.
doi: 10.1089/mdr.2021.0352. Epub 2022 May 27.

Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017

Affiliations

Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017

Susannah L McKay et al. Microb Drug Resist. 2022 Jun.

Abstract

Healthcare-associated carbapenem-resistant Acinetobacter baumannii (CRAB) infections are a serious threat associated with global epidemic clones and a variety of carbapenemase gene classes. In this study, we describe the molecular epidemiology, including whole-genome sequencing analysis and antimicrobial susceptibility profiles of 92 selected, nonredundant CRAB collected through public health efforts in the United States from 2013 to 2017. Among the 92 isolates, the Oxford (OX) multilocus sequence typing scheme identified 30 sequence types (STs); the majority of isolates (n = 59, 64%) represented STs belonging to the international clonal complex 92 (CC92OX). Among these, ST208OX (n = 21) and ST281OX (n = 20) were the most common. All isolates carried an OXA-type carbapenemase gene, comprising 20 alleles. Ninety isolates (98%) encoded an intrinsic OXA-51-like enzyme; 67 (73%) harbored an additional acquired blaOXA gene, most commonly blaOXA-23 (n = 45; 49%). Compared with isolates harboring only intrinsic oxacillinase genes, acquired blaOXA gene presence was associated with higher prevalence of resistance and a higher median minimum inhibitory concentration to the carbapenem imipenem (64 μg/mL vs. 8 μg/mL), and antibiotics from other drug classes, including penicillin, aminoglycosides, cephalosporins, and polymyxins. These data illustrate the wide distribution of CC92OX and high prevalence of acquired blaOXA carbapenemase genes among CRAB in the United States.

Keywords: Acinetobacter baumannii; MLST; WGS; carbapenem resistance; healthcare-associated infections; molecular epidemiology.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement

No competing financial interests exist.

Figures

FIG. 1.
FIG. 1.
Oxford MLST for CRAB isolates by geographic region. ST belonging to CC92OX are in blue. Non-CC92OX STs in gray. STs reported as the proportion of total isolates from that region. Total number of isolates for each region indicated in parentheses. “Other” category comprises STs with ≤3 total isolates and are listed, by CC, to the right of the graph. CC92, clonal complex 92; CRAB, carbapenem-resistant Acinetobacter baumannii; MLST, multilocus sequence typing; ST, sequence type.
FIG. 2.
FIG. 2.
Phylogenetic classification of 92 CRAB isolates based on whole-genome MLST reveals genetic diversity within CC92OX. Clonal complexes defined by BURST are indicated by colored circles. Numbers indicate Oxford MLST designations. Geographic region, acquired OXA, and drug resistance patterns are indicated by colored blocks. MDR, multidrug-resistant; PDR, pan drug-resistant; XDR, extensively drug-resistant.

References

    1. Bergogne-Berezin E, and Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev 9:148–165. - PMC - PubMed
    1. Karageorgopoulos DE, and Falagas ME. 2008. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet. Infect. Dis 8:751–762. - PubMed
    1. Theaker C, Azadian B, and Soni N. 2003. The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia 58:271–274. - PubMed
    1. CDC. 2021. Antibiotic resistance & patient safety portal: Carbapenem-resistant Acinetobacter. Available at https://arpsp.cdc.gov/profile/antibiotic-resistance/carbapenem-resistant... (accessed October 4, 2021).
    1. CDC. 2019. Antibiotic resistance threats in the United States, 2019 Available at https://www.cdc.gov/drugresistance/biggest-threats.html (accessed October 4, 2021).

MeSH terms

LinkOut - more resources